Global Omics Lab Services Industry Outlook 2025-2029: Market Set to Cross $194.52 Billion Milestone

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Omics Lab Services Market Size By 2025?
In recent years, the omics lab services market has experienced a swift expansion. The market, valued at $94.52 billion in 2024, is projected to reach $109.47 billion in 2025, with a compound annual growth rate (CAGR) of 15.8%. This significant increase over the historical period can be attributed to several factors, including enhanced government funding, the rise in personalized medicine, a high incidence of chronic illnesses, advancements in precision oncology, and the growth of the biotech and pharmaceutical sectors.

How Big Is the Omics Lab Services Market Size Expected to Grow by 2029?
The market size of omics lab services is set to experience a sharp rise in the coming years, with it anticipated to reach $194.52 billion in 2029, growing at a compound annual growth rate (CAGR) of 15.5%. This growth over the forecast period can be linked to the increasing demand for companion diagnostics, the growing use of liquid biopsies, the global expansion of clinical trials, the surge in chronic diseases prevalence, and a rise in biotechnology investment. The forecast period is expected to see several major trends such as fast-paced technological innovation, the creation of products for human genome sequencing, the incorporation of cloud analytics and big-data platforms, integrating multi-omics, and growing partnerships among pharmaceutical firms.

View the full report here:
https://www.thebusinessresearchcompany.com/report/omics-lab-services-global-market-report

Which Key Market Drivers Powering Omics Lab Services Market Expansion and Growth?
An increase in the occurrence of genetic disorders is projected to further boost the growth of the omics lab services market. Genetic disorders occur due to faults or alterations in an individual's DNA, which can be either inherited or arise spontaneously. With the advancement of diagnostic technologies, especially next-generation sequencing and other genomic tools, the detection and identification of a broader array of genetic diseases that earlier went unnoticed or were misdiagnosed, have drastically improved. Omics lab services contribute to the diagnosis of genetic diseases by examining intricate biological data to pinpoint mutations and molecular alterations, providing an opportunity for early detection and tailored treatment. For example, as per the Cystic Fibrosis Trust, a charity based in the UK committed to helping people with cystic fibrosis, in 2022, there were 11,148 registered cystic fibrosis patients, and this number increased to 11,318 in 2023, indicating a 1.5% year-over-year increase in patient registrations. Thus, the escalating occurrence of genetic disorders is fuelling the growth of the omics lab services market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28284&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Omics Lab Services Market?
Leading entities in the omics laboratory service market are investing in groundbreaking solutions, such as omics analysis services, to propel the progress of personalized medicine. This is done by providing a thorough blend of multi-omics and sophisticated data analytics. The term omics analysis services is used to denote comprehensive, data-oriented explorations of genes, RNA, proteins, metabolites, and epigenetic modifications, essential in comprehending intricate biological systems and aiding diverse applications. As an illustration, Bertis Inc., a biotechnology firm based in South Korea, inaugurated the Pan-omics Analysis Service & Solution (PASS) in May 2022. This platform was developed to aid clinical studies and pharmaceutical advancements by combining proteomics based on mass spectrometry with unique bioinformatics and AI technologies. The services it provides include protein identification, biomarker identification, support for drug development, and analytics for clinical research. With this initiative, Bertis has strategically diversified from diagnostics to advanced analytics, facilitating greater understanding of disease mechanisms and personalized treatment strategies.

What Are the Emerging Segments in the Omics Lab Services Market?
The omics lab services market covered in this report is segmented as

1) By Type Of Omics Services: Genomics, Transcriptomics, Proteomics, Metabolomics, Epigenomics
2) By Service Model: Contract Services, In-House Services, Consultative Services, Collaborative Research, Custom Solutions
3) By Technology Platform: Next-Generation Sequencing (NGS), Microarray Technology, Mass Spectrometry, Chromatography, Bioinformatics Tools
4) By Application: Drug Discovery, Diagnostics, Personalized Medicine, Other Applications
5) By End Users: Research Institutions, Pharmaceutical Companies, Biotechnology Firms, Academic Institutions, Clinical Laboratories

Subsegments:
1) By Genomics: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing, Single-Cell Genomics, Comparative Genomic Hybridization
2) By Transcriptomics: Messenger Ribonucleic Acid (RNA) Sequencing, Non-Coding Ribonucleic Acid (RNA) Sequencing, Expression Profiling, Ribonucleic Acid (RNA) Microarrays, Single-Cell Transcriptomics
3) By Proteomics: Protein Identification, Protein Quantification, Post-Translational Modifications Analysis, Protein-Protein Interaction Mapping, Structural Proteomics
4) By Metabolomics: Targeted Metabolomics, Untargeted Metabolomics, Lipidomics, Fluxomics, Metabolic Fingerprinting
5) By Epigenomics: Deoxyribonucleic Acid (DNA) Methylation Analysis, Histone Modification Profiling, Chromatin Accessibility Assays, Chromatin Immunoprecipitation Sequencing, Non-Coding Ribonucleic Acid (RNA) Epigenetic Regulation

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=28284&type=smp

Who Are the Global Leaders in the Omics Lab Services Market?
Major companies operating in the omics lab services market are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., Novogene Co. Ltd., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Macrogen Inc., MedGenome Labs Ltd., Metabolon Inc., Zymo Research Corporation, CD Genomics, BaseClear B.V., Strand Life Sciences Pvt. Ltd., Sengenics Corporation Pte Ltd., Psomagen Inc., Biocrates Life Sciences AG, Creative Proteomics.

Which are the Top Profitable Regional Markets for the Omics Lab Services Industry?
North America was the largest region in the omics lab services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=28284

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.